These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1107 related articles for article (PubMed ID: 1995878)
21. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis. Low JE; Borch RF; Sladek NE Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981 [TBL] [Abstract][Full Text] [Related]
22. Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines. Sladek NE; Landkamer GJ Cancer Res; 1985 Apr; 45(4):1549-55. PubMed ID: 3978623 [TBL] [Abstract][Full Text] [Related]
23. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro. Erickson LC; Ramonas LM; Zaharko DS; Kohn KW Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062 [TBL] [Abstract][Full Text] [Related]
24. In vivo antitumor, in vitro antibacterial activity and alkylating properties of phosphorohydrazine derivatives of coumarin and chromone. Nawrot-Modranka J; Nawrot E; Graczyk J Eur J Med Chem; 2006 Nov; 41(11):1301-9. PubMed ID: 16904795 [TBL] [Abstract][Full Text] [Related]
25. Conjugated system of homo-aza-steroidal esters in cancer chemotherapy. Catsoulacos P; Catsoulacos D Anticancer Res; 1994; 14(6B):2525-8. PubMed ID: 7872677 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the protonation of isophosphoramide mustard and phosphoramide mustard. Millis KK; Colvin ME; Shulman-Roskes EM; Ludeman SM; Colvin OM; Gamcsik MP J Med Chem; 1995 Jun; 38(12):2166-75. PubMed ID: 7783148 [TBL] [Abstract][Full Text] [Related]
27. Synthesis, base-catalyzed hydrolytic reactivity, and anticancer evaluation of O-aryl phosphorodiamidates as a novel class of pro(phosphorodiamidic acid mustards). Chiu FT; Tsui FP; Zon G J Med Chem; 1979 Jul; 22(7):802-7. PubMed ID: 448679 [TBL] [Abstract][Full Text] [Related]
28. [The synthesis and biologic activity of analogs of 1,4-benzoquinone-guanylhydrazone-thiosemicarbazone. 2. Substitution at the quinone ring by alkyl groups]. Schulze W; Gutsche W; Wohlrabe K; Tresselt D; Horn G; Fleck W Pharmazie; 1986 Feb; 41(2):99-101. PubMed ID: 3725863 [TBL] [Abstract][Full Text] [Related]
29. Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective. Friedman OM; Wodinsky I; Myles A Cancer Treat Rep; 1976 Apr; 60(4):337-46. PubMed ID: 1277209 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and tumor inhibiting activity of lanthanum (III) complexes with some 1-aminocycloalkancarboxylic acids. Kovachev TB; Ivanov DS; Buyukliev RT; Konstantinov SM; Karaivanova MC Pharmazie; 1996 Jan; 51(1):25-7. PubMed ID: 8999429 [TBL] [Abstract][Full Text] [Related]
31. The interaction of glutathione with 4-hydroxycyclophosphamide and phosphoramide mustard, studied by 31P nuclear magnetic resonance spectroscopy. Dirven HA; Venekamp JC; van Ommen B; van Bladeren PJ Chem Biol Interact; 1994 Dec; 93(3):185-96. PubMed ID: 7923439 [TBL] [Abstract][Full Text] [Related]
32. Identification of new aqueous chemical degradation products of isophosphoramide mustard. Breil S; Martino R; Gilard V; Malet-Martino M; Niemeyer U J Pharm Biomed Anal; 2001 Jun; 25(3-4):669-78. PubMed ID: 11377048 [TBL] [Abstract][Full Text] [Related]
33. Thermodynamic analysis of the reaction of phosphoramide mustard with protector thiols. Seitz DE; Katterjohn CJ; Rinzel SM; Pearce HL Cancer Res; 1989 Jul; 49(13):3525-8. PubMed ID: 2499418 [TBL] [Abstract][Full Text] [Related]
34. DNA-directed alkylating agents. 1. Structure-activity relationships for acridine-linked aniline mustards: consequences of varying the reactivity of the mustard. Gourdie TA; Valu KK; Gravatt GL; Boritzki TJ; Baguley BC; Wakelin LP; Wilson WR; Woodgate PD; Denny WA J Med Chem; 1990 Apr; 33(4):1177-86. PubMed ID: 2319563 [TBL] [Abstract][Full Text] [Related]
35. Synthesis of reactive metabolite-analogues of cyclophosphamide for comparisons of NMR kinetic parameters and anticancer screening data. Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K Drugs Exp Clin Res; 1986; 12(6-7):527-32. PubMed ID: 3743371 [TBL] [Abstract][Full Text] [Related]
36. A novel synthetic DNA minor groove binder, MS-247: antitumor activity and cytotoxic mechanism. Matsuba Y; Edatsugi H; Mita I; Matsunaga A; Nakanishi O Cancer Chemother Pharmacol; 2000; 46(1):1-9. PubMed ID: 10912571 [TBL] [Abstract][Full Text] [Related]
37. Nucleotide derivatives of 2,7-diaminomitosene. Iyengar BS; Dorr RT; Remers WA; Kowal CD J Med Chem; 1988 Aug; 31(8):1579-85. PubMed ID: 3397995 [TBL] [Abstract][Full Text] [Related]
38. N-(2,2-Dimethyl-2-(2-nitrophenyl)acetyl)-4-aminocyclophosphamide as a potential bioreductively activated prodrug of phosphoramide mustard. Jiang Y; Hu L Bioorg Med Chem Lett; 2008 Jul; 18(14):4059-63. PubMed ID: 18556201 [TBL] [Abstract][Full Text] [Related]
39. Synergistic antineoplastic and cytogenetic effects by the combined action of two homo-aza-steroidal esters of nitrogen mustards on P388 and L1210 leukaemias in vivo and in vitro. Nikolaropoulos S; Tsavdaridis D; Arsenou E; Papageorgiou A; Karaberis E; Mourelatos D Anticancer Res; 2000; 20(4):2745-51. PubMed ID: 10953353 [TBL] [Abstract][Full Text] [Related]
40. Biotransformation of mafosfamide in P388 mice leukemia cells: intracellular 31P-NMR studies. Sonawat HM; Leibfritz D; Engel J; Hilgard P Biochim Biophys Acta; 1990 Apr; 1052(1):36-41. PubMed ID: 2322593 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]